A combined approach needed to fight antibiotics resistance, research says

March 15, 2013, University of Abertay Dundee

(Medical Xpress)—In her latest report to the government, Professor Dame Sally Davies - the UK's Chief Medical Officer - says the current antibiotics resistance crisis poses a "catastrophic threat".

She uses the report to call for global action on the issue, saying that more innovation from pharmaceuticals companies in the development of is needed if we are to tackle it.

However, in a paper in The Lancet Infectious Diseases, Professor Wilfred Otten and colleagues argue that the solution to the antibiotic resistance crisis does not lie with medicine and the pharmaceuticals industry alone.

They believe that a combined approach addressing environmental, agricultural, social and medical factors is the only way to tackle this global problem.

Here, Professor Otten explains the key role the environment, and soils in particular, play in bringing antibiotic resistance under control.

"Society has become largely dependent on and they have been one of the greatest success stories of – they have transformed, and indeed prolonged, our lives.

"However, bacteria are rapidly developing resistance to antibiotics and the length of time that antibiotics will remain effective has been pinned down to just a few decades – a situation so serious that the UK's Chief Medical Officer is again urging the government to add it to the national risk register of civil emergencies.

"This is the third time in just four months that Professor Dame Sally Davies has highlighted the urgency of the situation, and the subject has quite rightly received much attention.

"However, most of this has focused on the behavioural causes of antibiotic resistance – GPs prescribing antibiotics for patients who do not need them, patients not completing the course of antibiotics they have been prescribed.

"But there is more to it than that. The natural environment, and how we interact with it, being key.

"Soil in particular plays an important role: just 1g of soil contains more bacteria than there are people on the planet, and these bacteria each naturally produce antibiotics to maintain a competitive edge over one another.

"By adding our own manmade antibiotics into the mix, the soil becomes the perfect breeding ground for new antibiotic-resistant strains to arise, as proximity makes it easy for the bacteria to exchange genes – which is how they evolve.

"And this is an important consideration because the amount of antibiotics that enter our soil systems every year, from a variety of sources, is vast.

"For example, more than half of all antibiotics used are given by us to animals. In the UK alone, about 350-400 tonnes of antibiotics were used each year in food-producing animals between 2006 and 2011 – and an estimated 70 million tonnes of that was spread onto agricultural land each year as well.

"And this is just one part of an ongoing cycle: the new, antibiotic-resistant bacteria in the soil can potentially enter our food chain when we eat the harvested crops and then, when they reach our gut, they can evolve again when they mix with the microflora that naturally live there.

"Once we excrete these bacteria, they enter our sewerage system and, from there, they can re-enter agricultural systems when sludge is used as a fertilizer, or when wastewater is used for irrigation.

"However, as well as agriculture and wastewater treatment, the manufacturing industry plays a major role.

"Although Professor Davies has called for pharmaceutical companies to invest in developing new antibiotics, it is current manufacturing practice in some countries that is actually exacerbating the problem.

"We have a Dangerous Substances Directive in Europe, which lists 129 substances that are regarded as so toxic that efforts to control their release should be given the highest priority. However, antibiotics are not on that list, so are not routinely tested for and their high prevalence in the environment has received little attention.

"This is a particular problem in countries such as China and India where antibiotic manufacturing occurs on a substantial scale but regulations tend to be somewhat lax. Rivers and soils become contaminated when wastewater from these factories is untreated, and both are widely used by humans and animals – for drinking, washing and for irrigation.

"And although such places may seem far away and of no consequence to us here in the UK, we travel much more widely these days, which means these pathogens are constantly crossing continents and building resistance in new and complex ways.

"So there is more to combating this problem than simply hoping for behavioural change amongst individuals – or the much needed development of new antibiotics – and there are a great number of players in this game who need to take responsibility for helping to control the rise of antibiotic resistance in the environment.

"It is clear that if we take action in one area, but not another, it will do little to control antibiotic resistance because so many factors are interdependent. So we need to work collaboratively, and internationally, with people from many different disciplines and areas of expertise if we are to combat what has become a truly global crisis."

Explore further: Antibiotic resistant bacteria proliferate in agricultural soils

More information: www.thelancet.com/journals/lan … (12)70317-1/fulltext

Related Stories

Antibiotic resistant bacteria proliferate in agricultural soils

March 20, 2012
Infectious diseases kill roughly 13 million people worldwide, annually, a toll that continues to rise, aided and abetted by resistance genes. Now a study, published in the March Antimicrobial Agents and Chemotherapy finds ...

Expert warning: Resistance to antibiotics to be apocalyptic

January 25, 2013
(Medical Xpress)—The chief medical officer for Britain's Department of Health has issued a warning that resistance to bacteria is a more urgent threat to humanity than global warming, with bacteria becoming resistant to ...

Small amounts of antibiotics generate big problems

July 22, 2011
New research conducted at Uppsala University shows that extremely low concentrations of antibiotics can enrich for antibiotic resistant bacteria. The research suggests that antibiotic residue introduced to the environment ...

Recognising the role of the environment in the global spread of antibiotic resistance

March 12, 2013
Antibiotic resistance has been recognised in recent years as a major healthcare problem, however, a paper in The Lancet Infectious Diseases reviewing the issue on a global scale, concludes that, not enough attention is given ...

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.